1Jon-Paul S Powers, Robert E W, Hancock. The relationship be- tween peptide structure and antibacterial activity[J]. Peptides, 2003,24=1 681-1 691.
2Hiromi Sato,Jimrny B Feix. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic a-helical antimicrobial peptides[J]. Biochimica et Biophysica Acta, 2006, 1758:1 245-1 256.
3Dekker N, Cox R C, et al. Substrate specificity of the integral membraneprotease Omp T determined by spatially addressed pep tide libraries[J]. Biochemistry,2001,40(6): 1 694-1 701.
4Hiromi Sato,Jimmy B Feix. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic n-helical antimierobial peptides[J]. Biochimica et Biophysica Acta, 2006, 1758:1 245-1 256.
5Wang Xiao dong. The expanding role of mitochondria in apoptosis [J]. Genes Dev. ,2001,15:2 922-2 933.
6Adam Szewezyk,Lech Wojtezak. Mitochondria as a Pharmacolog- ical Target[J]. Pharmacol Rev, 2002,54 : 101-127.
7Anthony S Don,Philip J Hogg. Mitochondria as cancer drug tar- gets[J]. Trends in Molecular Medicine, 2004, (10) : 372-378.
8Paola C,Etienne J. Mitochondrion as a novel target of anticancer [J]. J. Natl Cancer Inst. ,2000,92:1 042-1 053.
9Mai J C,Mi Z B,et al. A proapoptotic peptide for the treatment of solid tumors[J]. Cancer Res. ,2001,61:7 709-7 712.
